SCHEMBL25849353

SCHEMBL25849353

COc1cc2c3c(c4c(c2cc1N1CCOCC1)-c1ccc(C(F)(F)F)cc1C4(C)C)C=CC(c1ccccc1)(c1ccccc1)O3

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNIK Q9UKE5 1/20 0.37
ALDH1A1 P00352 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 7/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
MAPT P10636 3/20 0.33
KDM4E B2RXH2 3/20 0.33
NPSR1 Q6W5P4 1/20 0.33
GAA P10253 2/20 0.32
S1PR1 P21453 1/20 0.32
TP53 P04637 1/20 0.32
MEN1 O00255 1/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
KMT2A Q03164 1/20 0.32
AGER Q15109 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
RAF1 P04049 1/20 0.31
BRAF P15056 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25716498 0.97 TNIK (0.35) TNIKALDH1A1SMN1; SMN2LMNAL3MBTL1
SCHEMBL25605285 0.96 LMNA (0.35) TNIKALDH1A1SMN1; SMN2LMNAL3MBTL1
SCHEMBL25716497 0.94 TNIK (0.37) TNIKALDH1A1SMN1; SMN2LMNAL3MBTL1
SCHEMBL3961406 0.93 LMNA (0.37) TNIKALDH1A1SMN1; SMN2LMNAL3MBTL1
SCHEMBL25605286 0.93 RAF1 (0.33) TNIKALDH1A1SMN1; SMN2LMNAL3MBTL1
SCHEMBL25605288 0.92 LMNA (0.36) TNIKALDH1A1SMN1; SMN2LMNAL3MBTL1
SCHEMBL25605283 0.91 TNIK (0.32) TNIKALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL25844442 0.90 ALDH1A1 (0.33) ALDH1A1SMN1; SMN2L3MBTL1MAPTKDM4E
SCHEMBL25605051 0.90 DRD2 (0.34) ALDH1A1LMNAL3MBTL1MAPTKDM4E
SCHEMBL25605495 0.90 PIK3CA (0.36) TNIKALDH1A1LMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4269532-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES Hoya Lens Thailand Ltd. (TH) 2023-11-01 EP disclosed
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES HOYA LENS THAILAND LTD. (TH) 2023-10-26 US disclosed
US-20230227717-A1 PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND SPECTACLES HOYA LENS THAILAND LTD. (TH) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230340318-A1 PHOTOCHROMIC COMPOUND, PHOTOCHROMIC COMPOSITION, PHOTOCHROMIC ARTICLE, AND EYEGLASSES NR2E3, CRY1, RPS10 TNIK 4867/4885ALDH1A1 1091/4885SMN1; SMN2 3937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.